{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T20:55:24Z","timestamp":1772657724245,"version":"3.50.1"},"reference-count":29,"publisher":"Aging and Disease","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging and disease"],"published-print":{"date-parts":[[2020]]},"DOI":"10.14336\/ad.2020.0711","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T02:41:00Z","timestamp":1600742460000},"page":"1191","source":"Crossref","is-referenced-by-count":64,"title":["Research progress on Mesenchymal Stem Cells (MSCs), Adipose-Derived Mesenchymal Stem Cells (AD-MSCs), Drugs, and Vaccines in Inhibiting COVID-19 Disease"],"prefix":"10.14336","volume":"11","author":[{"given":"Pietro","family":"Gentile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aris","family":"Sterodimas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacopo","family":"Pizzicannella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Calabrese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Garcovich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5462","reference":[{"key":"key-10.14336\/AD.2020.0711-1","doi-asserted-by":"crossref","unstructured":"Dominici M, Le Blanc K, Mueller I, et al (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy, 8:315-317.","DOI":"10.1080\/14653240600855905"},{"key":"key-10.14336\/AD.2020.0711-2","doi-asserted-by":"crossref","unstructured":"Gentile P, Sterodimas A (2020). Adipose-derived stromal stem cells (ASCs) as a new regenerative immediate therapy combating coronavirus (COVID-19)-induced pneumonia. Expert Opin Biol Ther, 1-6","DOI":"10.1080\/14712598.2020.1761322"},{"key":"key-10.14336\/AD.2020.0711-3","doi-asserted-by":"crossref","unstructured":"Leng Z, Zhu R, Hou W, et al (2020). Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis, 11:216-228.","DOI":"10.14336\/AD.2020.0228"},{"key":"key-10.14336\/AD.2020.0711-4","doi-asserted-by":"crossref","unstructured":"Toyserkani NM, Jorgensen MG, Tabatabaeifar S, et al (2017). Concise review: A safety assessment of adipose-derived cell therapy in clinical trials: A systematic review of reported adverse events. Stem Cells Trans Med, 6:1786-1794.","DOI":"10.1002\/sctm.17-0031"},{"key":"key-10.14336\/AD.2020.0711-5","doi-asserted-by":"crossref","unstructured":"Wu Z, McGoogan JM (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA, Feb 24.","DOI":"10.1001\/jama.2020.2648"},{"key":"key-10.14336\/AD.2020.0711-6","doi-asserted-by":"crossref","unstructured":"Huang C, Wang Y, Li X, et al (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395:497-506","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"key-10.14336\/AD.2020.0711-7","doi-asserted-by":"crossref","unstructured":"Arentz M, Yim E, Klaff L, et al (2020). Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA, Mar 19.","DOI":"10.1001\/jama.2020.4326"},{"key":"key-10.14336\/AD.2020.0711-8","doi-asserted-by":"crossref","unstructured":"Behnke J, Kremer S, Shahzad T, et al (2020). MSC-based therapies-new perspectives for the injured lung. J Clin Med, 3;9(3). pii: E682.","DOI":"10.3390\/jcm9030682"},{"key":"key-10.14336\/AD.2020.0711-9","doi-asserted-by":"crossref","unstructured":"Manchikanti L, Centeno CJ, Atluri S, et al (2020). Bone marrow concentrate (BMC) therapy in musculoskeletal disorders: Evidence-based policy position statement of American Society of Interventional Pain Physicians (ASIPP). Pain Physician, 23:E85-E131.","DOI":"10.36076\/ppj.2020\/23\/E85"},{"key":"key-10.14336\/AD.2020.0711-10","unstructured":"Knoepfler P (2020). \u2018We Cannot Stick to the Rules\u2019: claims of stem cells saving COVID-19 patients. The Niche, March 3."},{"key":"key-10.14336\/AD.2020.0711-11","unstructured":"Lu R, Zhao X, Li J, et al (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 395:565-574."},{"key":"key-10.14336\/AD.2020.0711-12","doi-asserted-by":"crossref","unstructured":"Kuba K, Imai Y, Rao SA, et al (2005). A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nature Medicine, 11:875-879.","DOI":"10.1038\/nm1267"},{"key":"key-10.14336\/AD.2020.0711-13","doi-asserted-by":"crossref","unstructured":"Hamming I, Timens W, Bulthuis MLC, et al (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. Journal of Pathology, 203:631-637.","DOI":"10.1002\/path.1570"},{"key":"key-10.14336\/AD.2020.0711-14","unstructured":"Multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia (2020). Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi, 43:185-188."},{"key":"key-10.14336\/AD.2020.0711-15","doi-asserted-by":"crossref","unstructured":"Gao J, Tian Z, Yang X (2020). Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends, 14:72-73.","DOI":"10.5582\/bst.2020.01047"},{"key":"key-10.14336\/AD.2020.0711-16","doi-asserted-by":"crossref","unstructured":"Sheahan TP, Sims AC, Leist SR, et al (2020). Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun, 11:222.","DOI":"10.1038\/s41467-019-13940-6"},{"key":"key-10.14336\/AD.2020.0711-17","unstructured":"Ning WJ, Liu X, Luo WX (2020). Progress in research and development of therapeutic drugs and vaccines in novel coronavirus [J\/OL]. Journal of Xiamen University (Natural Science Edition): 1-7 [2020-04-14]."},{"key":"key-10.14336\/AD.2020.0711-18","doi-asserted-by":"crossref","unstructured":"Mantovani A, Sica A, Sozzani S, et al (2004). The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol, 25:677-686.","DOI":"10.1016\/j.it.2004.09.015"},{"key":"key-10.14336\/AD.2020.0711-19","doi-asserted-by":"crossref","unstructured":"Xu Z, Shi L, Wang Y, et al (2020). Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med, 8:420-422.","DOI":"10.1016\/S2213-2600(20)30076-X"},{"key":"key-10.14336\/AD.2020.0711-20","doi-asserted-by":"crossref","unstructured":"Alcayaga-Miranda F, Cuenca J, Khoury M (2017). Antimicrobial activity of mesenchymal stem cells: Current status and new perspectives of antimicrobialpeptide-based therapies. Front Immunol, 8:339.","DOI":"10.3389\/fimmu.2017.00339"},{"key":"key-10.14336\/AD.2020.0711-21","doi-asserted-by":"crossref","unstructured":"Krasnodembskaya A, Song Y, Fang X, et al (2010). Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells, 28:2229-2238.","DOI":"10.1002\/stem.544"},{"key":"key-10.14336\/AD.2020.0711-22","doi-asserted-by":"crossref","unstructured":"Sutton MT, Fletcher D, Ghosh SK, et al (2016). Antimicrobial properties of mesenchymal stem cells: therapeutic potential for cystic fibrosis infection and treatment. Stem Cells Int, 2016:12","DOI":"10.1155\/2016\/5303048"},{"key":"key-10.14336\/AD.2020.0711-23","doi-asserted-by":"crossref","unstructured":"Locke M, Windsor J, Dunbar PR (2009). Human adipose-derived stem cells: Isolation, characterization and applications in surgery. ANZ J Surg, 79:235-244.","DOI":"10.1111\/j.1445-2197.2009.04852.x"},{"key":"key-10.14336\/AD.2020.0711-24","doi-asserted-by":"crossref","unstructured":"Baglio SR, Rooijers K, Koppers-Lalic D, et al (2015). Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res Ther, 6:127.","DOI":"10.1186\/s13287-015-0116-z"},{"key":"key-10.14336\/AD.2020.0711-25","doi-asserted-by":"crossref","unstructured":"Manning CN, Martel C, Sakiyama-Elbert SE, et al (2015). Adipose-derived mesenchymal stromal cells modulate tendon fibroblast responses to macrophage-induced inflammation in vitro. Stem Cell Res Ther, 6:74.","DOI":"10.1186\/s13287-015-0059-4"},{"key":"key-10.14336\/AD.2020.0711-26","doi-asserted-by":"crossref","unstructured":"Lozito TP, Jackson WM, Nesti LJ, et al (2014). Human mesenchymal stem cells generate a distinct pericellular zone of MMP activities via binding of MMPs and secretion of high levels of TIMPs. Matrix Biol, 34:132-143.","DOI":"10.1016\/j.matbio.2013.10.003"},{"key":"key-10.14336\/AD.2020.0711-27","doi-asserted-by":"crossref","unstructured":"Gentile P, Sterodimas A (2020). Adipose Stem Cells (ASCs) and Stromal Vascular Fraction (SVF) as a Potential Therapy in Combating (COVID-19)-Disease. Aging Dis, 11:465-469.","DOI":"10.14336\/AD.2020.0422"},{"key":"key-10.14336\/AD.2020.0711-28","doi-asserted-by":"crossref","unstructured":"Bauer G, Elsallab M, Abou-El-Enein M (2018). Concise Review: A comprehensive analysis of reported adverse events in patients receiving unproven stem cell-based interventions. Stem Cells Transl Med, 7:676-685.","DOI":"10.1002\/sctm.17-0282"},{"key":"key-10.14336\/AD.2020.0711-29","doi-asserted-by":"crossref","unstructured":"Rogers CJ, Harman RJ, Bunnell BA, et al. (2020). Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients. Version 2. J Transl Med, 18:203","DOI":"10.1186\/s12967-020-02380-2"}],"container-title":["Aging and disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.aginganddisease.org\/fileup\/2152-5250\/PDF\/ad-0-0-2020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T02:45:17Z","timestamp":1627526717000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2020.0711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.14336\/ad.2020.0711","relation":{},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}